What are the Current Indications and Contraindications for a Splenectomy?

Article Sidebar

PDF
Published: Nov 15, 2022
DOI: https://doi.org/10.47191/ijmscrs/v2-i11-26
Keywords:
..

Main Article Content

Miguel Angel Flores-Delgado
Departamento de Cirugía, Unidad Médica de Alta Especialidad (UMAE), Hospital de Especialidades (HE), Centro Médico Nacional de Occidente (CMNO), IMSS, Guadalajara, Jalisco, México.
Diego Eduardo Saavedra Mayorga
Departamento de Anestesiología, Unidad Médica de Alta Especialidad (UMAE), Hospital de Especialidades (HE), Centro Médico Nacional de Occidente (CMNO), IMSS, Guadalajara, Jalisco, México.
Héctor Zúñiga-Gazcón
Departamento de Cirugía, Unidad Médica de Alta Especialidad (UMAE), Hospital de Especialidades (HE), Centro Médico Nacional de Occidente (CMNO), IMSS, Guadalajara, Jalisco, México.

Abstract

Splenectomy can treat conditions characterized by hemolysis or thrombocytopenia caused by autoantibodies or splenic reticuloendothelial function, as well as disorders characterized by massive splenomegaly and hypersplenism with cytopenias, such as hereditary spherocytosis, transfusion-dependent thalassemia, immune thrombocytopenia, autoimmune hemolytic anemia, splenic marginal zone lymph Splenectomy is no longer used for Hodgkin disease staging and is typically avoided in autoimmune lymphoproliferative syndrome, hereditary stomatocytosis or xerocytosis, cold agglutinin disease, paroxysmal cold hemoglobinuria, Gaucher disease, and cirrhosis-related hypersplenism.

Article Details

How to Cite
Flores-Delgado, M. A. ., Saavedra Mayorga, D. E. ., & Zúñiga-Gazcón, H. . (2022). What are the Current Indications and Contraindications for a Splenectomy?. International Journal of Medical Science and Clinical Research Studies, 2(11), 1293–1295. https://doi.org/10.47191/ijmscrs/v2-i11-26
Issue
Vol. 2 No. 11 (2022): Volume 02 Issue 11 November 2022
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

I. Bonnet, S., Guédon, A., Ribeil, J. A., Suarez, F., Tamburini, J., & Gaujoux, S. (2017). Indications and outcome of splenectomy in hematologic disease. Journal of visceral surgery, 154(6), 421-429.

II. Iolascon, A., Andolfo, I., Barcellini, W., Corcione, F., Garçon, L., De Franceschi, L., ... & Tamary, H. (2017). Recommendations regarding splenectomy in hereditary hemolytic anemias. haematologica, 102(8), 1304.

III. Da Costa, L., Galimand, J., Fenneteau, O., & Mohandas, N. (2013). Hereditary spherocytosis, elliptocytosis, and other red cell membrane disorders. Blood reviews, 27(4), 167-178.

IV. Muncie Jr, H. L., & Campbell, J. S. (2009). Alpha and beta thalassemia. American family physician, 80(4), 339-344.

V. Al-Salem, A. H. (2011). Splenic complications of sickle cell anemia and the role of splenectomy. International Scholarly Research Notices, 2011.

VI. Grace, R. F., Zanella, A., Neufeld, E. J., Morton, D. H., Eber, S., Yaish, H., & Glader, B. (2015). Erythrocyte pyruvate kinase deficiency: 2015 status report. American journal of hematology, 90(9), 825-830.

VII. Sandler, S. G. (2000, January). The spleen and splenectomy in immune (idiopathic) thrombocytopenic purpura. In Seminars in hematology (Vol. 37, pp. 10-12). WB Saunders.

VIII. Cines, D. B., & Blanchette, V. S. (2002). Immune thrombocytopenic purpura. New England Journal of Medicine, 346(13), 995-1008.

IX. Lechner, K., & Jäger, U. (2010). How I treat autoimmune hemolytic anemias in adults. Blood, The Journal of the American Society of Hematology, 116(11), 1831-1838.

X. Capsoni, F., Sarzi-Puttini, P., & Zanella, A. (2005). Primary and secondary autoimmune neutropenia. Arthritis research & therapy, 7(5), 1-7.

XI. Freedman, A. S., Aster, J. C., & Friedberg, J. W. Splenic marginal zone lymphoma.

XII. Radcliffe, C., Tang, Z., Gisriel, S. D., & Grant, M. (2022, April). Splenic Abscess in the New Millennium: A Descriptive, Retrospective Case Series. In Open Forum Infectious Diseases (Vol. 9, No. 4, p. ofac085). US: Oxford University Press.

XIII. Weber, S. M., & Rikkers, L. F. (2003). Splenic vein thrombosis and gastrointestinal bleeding in chronic pancreatitis. World journal of surgery, 27(11), 1271-1274.

XIV. Hennessy, B. T., Coleman, R. L., & Markman, M. (2009). Ovarian cancer. The lancet, 374(9698), 1371-1382.

XV. Li, P., Huang, P., Yang, Y., Hao, M., Peng, H., & Li, F. (2016). Updated understanding of autoimmune lymphoproliferative syndrome (ALPS). Clinical reviews in allergy & immunology, 50(1), 55-63.

XVI. Shanbhag, S., & Spivak, J. (2015). Paroxysmal cold hemoglobinuria. Hematology/Oncology Clinics, 29(3), 473-478.

XVII. Shachar, T., Bianco, C. L., Recchia, A., Wiessner, C., Raas‐Rothschild, A., & Futerman, A. H. (2011). Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond. Movement Disorders, 26(9), 1593-1604.

XVIII. Andolfo, I., Russo, R., Gambale, A., & Iolascon, A. (2016). New insights on hereditary erythrocyte membrane defects. Haematologica, 101(11), 1284.

XIX. McCormick, P. A., & Murphy, K. M. (2000). Splenomegaly, hypersplenism and coagulation abnormalities in liver disease. Best Practice & Research Clinical Gastroenterology, 14(6), 1009-1031.

Most read articles by the same author(s)